STOCK TITAN

Quest Diagnostics to Release Fourth Quarter and Full Year 2022 Financial Results on February 2, 2023

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) will announce its fourth quarter and full year 2022 financial results on February 2, 2023, prior to market opening. A conference call detailing these results will begin at 8:30 a.m. ET on the same day. Participants can dial in at 888-455-0391 (U.S. and Canada) or 773-756-0467 (international) with the passcode '7895081'. The earnings release and a live webcast will be available on www.QuestDiagnostics.com/investor. A replay of the call will be accessible from 10:30 a.m. ET on February 2 until midnight ET on February 16, 2023.

Positive
  • None.
Negative
  • None.

SECAUCUS, N.J., Jan. 20, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2022 financial results on Thursday, February 2, 2023, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. 

The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor. The company suggests participants dial in approximately 10 minutes before the call. 

A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 888-566-0498 for domestic callers or 203-369-3056 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on February 2, 2023 until midnight Eastern Time on February 16, 2023.

Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.  www.QuestDiagnostics.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-2-2023-301727278.html

SOURCE Quest Diagnostics

FAQ

When will Quest Diagnostics report its Q4 2022 financial results?

Quest Diagnostics will report its Q4 2022 financial results on February 2, 2023.

What time is the Quest Diagnostics earnings conference call?

The earnings conference call for Quest Diagnostics will begin at 8:30 a.m. ET on February 2, 2023.

How can I access the Quest Diagnostics earnings call?

You can access the earnings call by dialing 888-455-0391 (U.S. and Canada) or 773-756-0467 (international) with the passcode '7895081'.

Where can I find the earnings release for Quest Diagnostics?

The earnings release will be posted on the Quest Diagnostics investor relations website at www.QuestDiagnostics.com/investor.

Is there a replay available for the Quest Diagnostics earnings call?

Yes, a replay of the earnings call will be available online from 10:30 a.m. ET on February 2 until midnight ET on February 16, 2023.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

17.04B
111.10M
0.43%
91.58%
1.83%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SECAUCUS